Davies, Andrew J; Barrans, Sharon; Stanton, Louise; Caddy, Josh; Wilding, Sam; Saunders, Geoff; Mamot, Christoph; Novak, Urban; McMillan, Andrew; Fields, Paul; Collins, Graham P; Stephens, Richard; Cucco, Francesco; Sha, Chulin; van Hoppe, Moniek; Tooze, Reuben; Davies, John R; Griffiths, Gareth; Schuh, Anna; Burton, Catherine; ... (2023). Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(15), pp. 2718-2723. American Society of Clinical Oncology 10.1200/JCO.23.00033
Snell, L B, Bakrania, P, Williams, T G S, Tam, J, Da Silva Fontoura, D, Shaw, E, Daunt, A, Edgeworth, J, Hemsley, C J, Fields, P, Agarwal, S, Lams, B, Cahill, H, Milligan, I, Botgros, A, Nebbia, G, Douthwaite, S & Aarons, E J 2022, ' Severe COVID-19 caused by persistent SARS-CoV-2 infection successfully treated with dual direct acting antivirals ', preprint .